Abivax SA American Depositary Shares (ABVX) — Cash Flow-to-Debt Ratio
Abivax SA American Depositary Shares (ABVX) has a Cash Flow-to-Debt Ratio of -0.43x as of March 2026, meaning its operating cash flow of $-50.52 Million could theoretically repay 0% of its total liabilities ($117.55 Million) in one year. See Abivax SA American Depositary Shares leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Abivax SA American Depositary Shares Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Abivax SA American Depositary Shares across 12 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Abivax SA American Depositary Shares.
Annual Cash Flow-to-Debt Ratio for Abivax SA American Depositary Shares (2014–2025)
Year-by-year debt coverage analysis for Abivax SA American Depositary Shares.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.21x | $-155.69 Million | $129.08 Million | ▼ -28.9% |
| 2024 | -0.94x | $-154.07 Million | $164.64 Million | ▼ -22.6% |
| 2023 | -0.76x | $-100.01 Million | $131.05 Million | ▲ +3.3% |
| 2022 | -0.79x | $-53.94 Million | $68.36 Million | ▼ -45.9% |
| 2021 | -0.54x | $-45.05 Million | $83.30 Million | ▲ +3.2% |
| 2020 | -0.56x | $-29.82 Million | $53.40 Million | ▲ +32.6% |
| 2019 | -0.83x | $-27.47 Million | $33.14 Million | ▼ -10.1% |
| 2018 | -0.75x | $-14.60 Million | $19.39 Million | ▲ +49.8% |
| 2017 | -1.50x | $-8.45 Million | $5.63 Million | ▲ +62.7% |
| 2016 | -4.02x | $-15.61 Million | $3.88 Million | ▼ -21.5% |
| 2015 | -3.31x | $-14.90 Million | $4.50 Million | ▼ -304.0% |
| 2014 | -0.82x | $-3.31 Million | $4.03 Million | — |